Drugs
(XML - 16KB)Current Drug Shortages E - K
The information provided in this section is provided voluntarily by manufacturers. FDA cannot require firms to report the reason for shortage or duration of the shortage or any other information about shortages. FDA appreciates all information provided by manufacturers. We post information about shortages as soon as we receive it from the manufacturers. To report information about shortages or supply issues, manufacturers can send updates to drugshortages@fda.hhs.gov. Healthcare professionals and patients are also encouraged to notify us of shortages at drugshortages@fda.hhs.gov.
*Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012
Epinephrine Injection (Initial Posting Date) – 4/27/2012
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service: 1-877-946-7747 | 1:10,000; 10 mL Abboject-1 ½ “ needle(NDC 0409-4921-34) | Next delivery September/ Estimated recovery 2Q 2013 | Please check with your wholesaler for available inventory. Shortage per Manufacturer: | Other | Revised 8/31/2012 |
| 1:10,000; 10 mL Abboject-3 ½ “ needle (NDC 0409-4901-18) | Next delivery September/ Estimated recovery December | ||||
| Amphastar Pharmaceuticals, Inc./IMS Customer Service: 1-800-423-4136 | 1:10,000, 10mL Luer-Jet Prefilled Syringe
NDC 76329-3316-1 (old NDC 0548-3316-00) | Amphastar will regularly release products. | Amphastar is experiencing a product shortage due to an increase in product demand caused by market supply issues. Shortage by Manufacturer: | Demand increase for the drug | Reverified 8/14/2012 |
Epinephrine 1mg/mL (Preservative Free) (Initial posting-6/21/12)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service: 1-877-946-7747 | 1 mg/mL, 1 mL ampule, preservative-free (contains sulfite), package of 25 (NDC 00409-7241-01) | Available | Shortage per Manufacturer: Available | Other | Revised 8/31/2012 |
| JHP Pharma 1-877-547-4547 | 1 mg/mL, 1 mL vial, preservative-free (contains sulfite), package of 25 (NDC 42023-122-25) | Next delivery: late September/ early October | Higher than anticipated market demand | Demand increase for the drug | Revised 9/11/2012 |
| American Regent/Luitpold 1-800-645-1706 | 30 mL vial, package of 5 (NDC 00517-1130-05) | Unavailable | American Regent is currently not releasing Epinephrine Injection. | Other | Reverified 8/31/2012 |
| 1 mg/mL, 1 mL ampule, (sulfite-free) package of 25 (NDC 00517-1071-25) |
Erythromycin Lactobionate Injection (Initial posting-6/12/12)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira Inc. Customer Service: 1-877-946-7747 | 500 mg/vial; (NDC 0409-6482-01) | Next delivery September/Estimated recovery: October | Please check with your wholesaler for available inventory. Shortage per Manufacturer: | Demand increase for the drug. | Revised 8/31/2012 |
Esomeprazole (Nexium) For Delayed-Release Oral Suspension (Initial Posting Date) - 4/10/2012
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| AstraZeneca 1-800-236-9933 | 20 mg packets, unit: dose packages of 30 (NDC 0186-4020-01) | Limited availability through September | Order management will remain in effect through September. Shortage per Manufacturer: | Other | Revised 9/4/2012 |
Ethiodol (ETHIODIZED OIL) ampules
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Guerbet LLC Customer Service (1-877-729-6679) | Guerbet has acquired the Ethiodol NDA from Nycomed US Inc. effective May 7, 2010 and is working with FDA to resume manufacturing of Ethiodol in the near future to ensure continued availability for the US patients. | During this interim period, Guerbet, in conjunction with the FDA, is initiating a temporary importation of LIPIODOL ULTRA-FLUIDE, ethyl esters of iodized fatty acids of poppy seed oil, to the United States market. Shortage per Manufacturer: | Discontinuation of the manufacture of the drug. | Revised 3/16/2012 |
Etomidate Injection (Initial Posting Date) - 2/9/2012
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
Sagent Pharmaceuticals 1-866-625-1618 | 2 mg/mL 10 mL vial (NDC 25021-0674-10) | Backordered with no restock date available | Delay in shipping of the drug. Demand incrase for the drug. | Reverified 9/10/2012 | |
2 mg/mL 20 mL vial (NDC 25021-0674-20) | |||||
| American Regent/Luitpold 1-800-645-1706 | 2 mg/mL vial 10 mL vial (NDC 00517-0780-10) | Unavailable | Please check with your wholesaler for available inventory.
Shortage per manufacturer: American Regent is currently not releasing the 20 mL vial size of Etomidate Injection.
| Other | Revised 8/31/2012 |
| 20 mL vial (NDC 00517-0781-10) | Unavailable | ||||
| Hospira Inc. Customer Service 1-877-946-7747 | 2 mg/mL; 10 mL vial (NDC 0409-6695-01) | Next delivery September/ Estimated recovery December | Please check with your wholesaler for available inventory.
Shortage per Manufacturer:
| Other | Revised 8/31/2012 |
| 2 mg/mL; 20 mL vial (NDC 0409-6695-02) | Next delivery September/Estimated recovery 2Q 2013 | ||||
| 2 mg/mL; 20 mL Abboject syringe (NDC 0409-8060-29) | Next delivery October/Estimated recovery 1Q 2013 | ||||
| 2 mg/mL; 20 mL amp (NDC 0409-8061-01) | Next delivery October/Estimated recovery December | ||||
| 2 mg/mL; 10 mL amp (NDC 0409-8062-01) | Next delivery October/Estimated recovery December | ||||
| Bedford Customer Service: 1-800-562-4797 | 2 mg/mL injection 10 mL vial (NDC 55390-0762-10) | Etomidate injection is on back order with no estimated date of availability. | Shortage per Manufacturer: Manufacturing Delay | Discontinuation of the manufacture of the drug. | |
| 20 mL (NDC 55390-0763-20) | |||||
| Pfizer Customer Service: Pfizer Injectables 1-800-533-4535 | 20 mg/10ml injection (NDC 0069-0006-01) | Pfizer has limited supply of etomidate injection, 20 mg/10ml injection (NDC 0069-0006-01) and 40mg/20ml injection (NDC 0069-0006-03). | Shortage per Manufacturer: | Other | Reverified 5/21/2012
|
| 40 mg/20ml injection (NDC 0069-0006-03) | |||||
Mylan Institutional 1-888-258-4199 | 2mg/mL, 20ml, 10s (NDC 67457-183-20) | Next shipment September 2012 | On back order | Demand increase for the drug. | Reverified 9/5/2012 |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service: 1-877-946-7747 | 0.05 mg/mL; 2 mL Carpuject (0409-1276-32) | Next delivery September/Estimated recovery 1Q 2013 | Carpuject orders (NDC 0409-1276-32) must be ordered through the wholesaler; check with your wholesaler regarding product allocation. It is recommended that the user institute fentanyl sparing strategies. Shortage per Manufacturer:
| Other | Revised 8/31/2012 |
| 0.05 mg/mL; 2 mL amp (0409-9093-32) | Next delivery October/Estimated recovery 1Q 2013 | ||||
| 0.05 mg/mL; 5 mL amp (0409-9093-35) | Available | ||||
| 0.05 mg/mL; 20 mL amp (0409-9093-38) | Next delivery October/Estimated recovery 1Q 2013 | ||||
| 0.05 mg/mL; 2 mL vial (0409-9094-22) | Next delivery October/Estimated recovery 1Q 2013 | ||||
| 0.05 mg/mL; 5 mL vial (0409-9094-25) | Next delivery October/Estimated recovery 1Q 2013 | ||||
| 0.05 mg/mL; 10 mL vial (0409-9094-28) | Next anticipated delivery November/Estimated recovery 1Q 2013 | ||||
| 0.05 mg/mL; 20 mL vial (0409-9094-31) | Next anticipated delivery September | ||||
| 0.05 mg/mL; 50 mL vial (0409-9094-61) | Next anticipated delivery October/Estimated recovery December | ||||
| West-Ward Pharmaceuticals Customer Service: 1-800-631-2174 (Formerly a Baxter Product) | 50 mcg/mL 2 mL ampul(NDC 0641-6024-10) | West-Ward has limited quantities available for all Fentanyl presentations. Additional lots are scheduled for manufacturing with the following availability: Multiple lots of the 2 mL, 5 mL, and 20 mL ampuls are anticipated to be released and available in the July - August 2012 timeframe. Additional lots of the 2 mL, 5 mL, 20 mL, and 50 mL vials are also scheduled to be available in the July - August 2012 timeframe. | West-Ward has continued to accelerate production on all codes. Product will be made available as it is released. Shortage per Manufacturer:
| Demand increase for the drug. | Revised 7/9/2012 |
50 mcg/mL 5 mL ampul (NDC 0641-6025-10) | |||||
50 mcg/mL 20 mL ampul (NDC 0641-6026-05) | |||||
50 mcg/mL 2 mL vial (NDC 0641-6027-25) | |||||
50 mcg/mL 5 mL vial (NDC 0641-6028-25) | |||||
50 mcg/mL 20 mL vial (NDC 0641-6029-25) | |||||
50 mcg/mL 50 mL vial (NDC 0641-6030-01) | |||||
| Akorn Pharmaceuticals 1-800-932-5676 | 2 mL ampule (NDC 17478-0030-02) | Readily available |
| Other | Revised 8/15/2012 |
2 mL ampule; 25 pack (NDC 17478-0030-25) | |||||
| 5 mL ample (NDC 17478-0030-05) | |||||
| 20 mL ample (NDC 17478-0030-20) |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service 1-877-946-7747 | 24 mg/mL; 250 mL bottle (NDC 0409-3863-02) | Hospira has discontinued Foscarnet Sodium and now sells and distributes Clinigen’s Foscavir. See Clinigen posting below. | Effective July, 2012, Hospira sells and distributes Clinigen’s Foscavir, which is now FDA approved and available in the US. Shortage per Manufacturer: | Discontinuation of the manufacture of the drug. | Reverified 8/31/2012 |
| 24 mg/mL; 500 mL bottle (NDC 0409-3863-05) | |||||
| Clinigen Healthcare | 24 mg/mL; 250 mL bottle | Effective July 11, 2012 Foscavir is available in the US. | Clinigen’s distributor is Hospira Inc. To order product, please contact Hospira, requesting list no. #1182-02. Shortage per Manufacturer: | Other | Revised 7/13/2012 |
Fosphenytoin Sodium Injection (Initial posting 3/30/12)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service 1-877-946-7747 | 75 mg/mL; 2 mL vial (NDC 0409-4857-02) | Production of both presentations is temporarily suspended. | Shortage per Manufacturer: Temporarily suspended production. | Discontinuation of the manufacture of the drug. | Reverified 8/31/2012 |
| 75 mg/mL; 50 mL vial (NDC 0409-4857-10 | |||||
| APP Customer Service 1-888-386-1300 | NDC # 63323-403-02 (100 mg PE/2 mL, 2 mL vial) | Next releases expected late September | All presentations currently back-ordered. Check wholesalers for available inventory. Shortage per Manufacturer: | Demand increase for the drug. | Reverified 8/27/2012 |
| NDC # 63323-403-10 (500 mg PE/10 mL, 10 mL vial) | |||||
West-Ward Pharmaceuticals
50 mg PE/mL | 2 mL vial (NDC 0143-9788-25) | Both presentations on backorder. At this time, West-Ward does not have a projected availability date. | Shortage per Manufacturer: Manufacturing delays | Demand increase for the drug. | Revised 5/9/2012 |
| 10 mL vial (NDC 0143-9782-10) |
Fospropofol disodium (Lusedra) Injection (Initial posting-6/18/12)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Eisai Inc Customer Service number- 1-888-422-4743 | 1050 mg/30 mL (35 mg/mL), 30 mL vial (NDC 62856-350-08) | Product is no longer available. | Shortage per Manufacturer: | Other | Revised 8/28/2012 |
Furosemide Injection (Initial posting-6/20/12)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira Inc. Customer Service: 1-877-946-7747 | 10 mg/mL; 4 mL Ansyr Syringe (NDC 0409-9631-04) | Next delivery November/Estimated recovery 1Q 2013 | Please check with your wholesaler for available inventory.
Shortage per Manufacturer: | Other | Revised 8/13/2012 |
| 10 mg/mL; 2mL vial (NDC 0409-6102-02 | Next delivery October/Estimated recovery 1Q 2013 | ||||
| 10 mg/mL; 4mL vial (NDC 0409-6102-04) | Next delivery September/Estimated recovery 1Q 2013 | ||||
| 10 mg/mL;10mL vial (NDC 0409-6102-10) | Next delivery October/Estimated recovery 1Q 2013 | ||||
| APP 1-888-386-1300 | 20 mg/2 mL, SDV (NDC 63323-028-002) | Next delivery anticipated late September | All presentations currently back-ordered. Check wholesalers for available inventory. Shortage per Manufacturer: | Demand increase for the drug. | Revised 8/27/2012 |
| 40 mg/4 mL, SDV (NDC 63323-028-004) | Next delivery anticipated mid-October | ||||
| 100 mg/10 mL, SDV (NDC 63323-028-010) | Next delivery anticipated late September | ||||
| American Regent/ Luitpold 1-800-645-1706 | 10 mg/mL 2 mL vial (NDC 00517-5702-25) | Unavailable | American Regent is currently not releasing Furosemide Injection, USP. | Reverified 8/31/2012 | |
| 10 mg/mL 4 mL vial (NDC 00517-5704-25) | Unavailable | ||||
| 10 mg/mL 10 mL vial (NDC 00517-5710-25) | Unavailable |
Ganite (gallium nitrate injection) (Initial Posting - 4/4/2012)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Genta Incorporated 1-888-TO-GENTA) | No estimated date of availability. | Business decision | Discontinuation of the manufacture of the drug. | 4/4/2012 |
Helidac (bismuth subsalicylate/tetracycline hydrochloride/metronidazole) Therapy (Initial Posting - 3/8/2012)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Prometheus Laboratories Inc. 1-888-423-5227 option 3 | HELIDAC (bismuth subsalicylate/tetracycline hydrochloride/metronidazole) Therapy (NDC 65483-495-14) | Prometheus has limited product available and cannot estimate a release date for new batches. | Shortage per Manufacturer: Material Shortage (Tetracycline HCl capsules) | Shortage of an active ingredient. | 4/4/2012 |
Heparin Sodium Premixes (Initial Posting - 7/5/2012)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
Hospira Inc. Customer Service: | Heparin sodium 50 U/mL in 0.45% sodium chloride; 250 mL container | Next delivery June 2013. | Please check with your wholesaler for available inventory. Shortage per Manufacturer: | Other | Revised 8/31/2012 |
Heparin sodium 50 U/mL in .045% sodium chloride; 500 mL container | Next delivery June 2013. | ||||
Heparin sodium 100 U/mL in 0.45% sodium chloride; 250 mL container (NDC 0409-7650-62) | Next delivery June 2013. | ||||
Heparin sodium 100 U/mL in 5% dextrose; 250 mL container | Next delivery June 2013. | ||||
Heparin sodium 50 U/mL in 5% dextrose; 250 mL container | Next delivery June 2013. | ||||
Heparin sodium 40 U/mL in 5% dextrose; 500 mL container | Next delivery September 2013. | ||||
Heparin sodium 50 U/mL in 5% dextrose; 500 mL container | Next delivery September 2013. |
Hydromorphone Hydrochloride Injection (Initial Posting-3/7/12)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service: 1-877-946-7747 | 1 mg/mL; 1 mL amp (NDC 0409-2552-01) | Next delivery September/Estimated recovery September | Please check with your wholesaler for available inventory. Shortage per Manufacturer:
| Demand increase for the drug | Revised 8/31/2012 |
| 1 mg/mL; 1 mL iSecure (NDC 0409-1283-10) | Next delivery October/Estimated recovery December | ||||
| 1 mg/mL; 1 mL Carpuject (NDC 0409-1283-31) | Next delivery August/Estimated recovery December | ||||
| 2 mg/mL; 1 mL vial (NDC 0409-3365-01) | Next delivery October/Estimated recovery December | ||||
| Product 2 mg/mL; 1 mL amp (NDC 0409-3356-01) | Next delivery September/Estimated recovery October | ||||
| 4mg/mL; 1mL Carpuject (NDC 0409-1304-31) | Next delivery October/Estimated recovery October | ||||
| 2 mg/mL; 1 mL iSecure (NDC 0409-1312-10) | Next delivery October/Estimated recovery October | ||||
| 2mg/mL; 1mL Carpuject (NDC 0409-1312-30) | Available | ||||
| 10mg/mL; 1mL Vial (NDC 0409-2634-01) | Available | ||||
| 10 mg/mL; 5 mL vial (NDC 0409-2634-05) | Available | ||||
| 10 mg/mL; 50 mL vial (NDC 0409-2634-50) | Available | ||||
| Teva Pharmaceuticals 1-800-545-8800 | 10 mg/mL, 1 mL vials (NDC 00703-0110-03) | Teva has all presentations available. | Shortage per Manufacturer: Increased Demand | Demand increase for the drug. | Reverified 8/17/2012 |
| 10 mg/mL, 5 mL vials (NDC 00703-0113-03) | |||||
| 10 mg/mL, 50 mL vials (NDC 00703-0118-01) | |||||
| West-Ward Pharmaceuticals Customer Service: 1-888-229-0001 | 1 mL vial, 2 mg/mL (NDC 0641-0121-25) |
West-Ward has limited quantities available for both the 1 mL and 20 mL vial presentations. West-Ward has increased production and is anticipating having additional lots of both presentations available in July - August 2012. | Product will be made available as it is released Shortage per Manufacturer: | Demand increase for the drug. | Revised 7/9/2012 |
| 20 mL vial, 2 mg/mL (NDC 0641-2341-41) | |||||
Akorn Pharmaceuticals
| 10 mg/mL, 1 mL ampules (NDC 17478-0540-01) | Readily available | Other
| Revised 8/13/2012 | |
| 10 mg/mL, 5 mL ampules (NDC 17478-0540-05) | Available in wholesalers, releasing late August | ||||
| 10 mg/mL, 50 mL vials (NDC 17478-0540-50) | Available in wholesalers | Quota request filed (Per manufacturer) Shortage per Manufacturer:
| |||
Purdue Pharma, L.P. Customer Service 800.877.5666 | Dilaudid injection: 1 mg/mL, 1 mL ampules, package of 10 (NDC 59011-0441-10) | Available | Shortage of an active ingredient | Shortage of an active ingredient | Revised 8/28/2012 |
| Dilaudid injection: 2 mg/mL, 1 mL ampules, package of 10 (NDC 59011-0442-10) | Backordered until September 2012 | ||||
| Dilaudid injection: 2 mg/mL, 1 mL ampules, package of 25 (NDC 59011-0442-25) | Available | ||||
| Dilaudid injection: 4 mg/mL, 1 mL ampules, package of 10 (NDC 59011-0444-10) | Available | ||||
| Dilaudid-HP injection 250 mg vial, powder for injection (NDC 59011-0446-25) | Available | ||||
Dilaudid-HP injection 10 mg/mL, 1 mL ampules (NDC 59011-0445-01) | Available | ||||
Dilaudid-HP injection 10 mg/mL, 5 mL ampules (NDC 59011-0445-05) | Available | ||||
| Dilaudid-HP injection 10 mg/mL, 50 mL vials (NDC 59011-0445-50 | Available |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira Inc. Customer Service: 1-877-946-7747 | 10%; 250 mL (NDC 0409-9790-02) | Hospira continues to investigate manufacturing process improvements. | Shortage per Manufacturer: Quality improvement activities | Requirements related to complying with good manufacturing practices | Reverified 8/31/2012 |
| 10%; 500 mL (NDC 0409-9790-03) | |||||
| 20%; 250 mL (NDC 0409-9791-02) | |||||
| 20%; 500 mL (NDC 0409-9791-03) | |||||
| 30%; 500 mL (NDC 0409-6892-03) | |||||
| Baxter (Intralipid Emulsion) Customer Service: (1-888-229-0001) | Intralipid 20% Emulsion, 100 mL (NDC 00338-0519-48) 20% | Available | Available
| Other | Reverified 8/23/2012 |
| Intralipid 20% Emulsion, 250 mL (NDC 00338-0519-02) | |||||
| Intralipid 20% Emulsion, 500 mL (NDC 00338-0519-03) | |||||
| Intralipid 20% Emulsion, 1000 mL (NDC 00338-0519-04) | |||||
| Intralipid 30% Emulsion, 500 mL (NDC 00338-0520-03) |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
Teva Customer Service: (888)838-2872 | 300 mg, 30 count (NDC 00555-0071-01) | Available. Inventory will remain low until end of year. | As of August 16, low inventory levels of (NDC 00555-0071-02) and (NDC 00555-0071-05). Will potentially go on/off backorder for balance of 2012. Shortage per Manufacturer: Manufacturing delays | Other | Revised 8/16/2012 |
300 mg, 100 count (NDC 00555-0071-02) | Available. Inventory will remain in low until end of year. | As of July 18, low inventory levels, and will potentially go on/off backorder for balance of 2012. | |||
300 mg, 1000 count (NDC 00555-0071-05) | Available. Inventory will remain in low until end of year. | As of July 18, low inventory levels, and will potentially go on/off backorder for balance of 2012 | |||
100 mg, 100 count (NDC 00555-0066-02) | Available. Teva supply adequate to meet demand. | ||||
100 mg, 1000 count (NDC 00555-0066-05) | Available. Teva supply adequate to meet demand. | ||||
Sandoz Customer Service: 1-609-627-8500 | 300 mg, 30s (NDC 00185-4350-30) | Estimate available late-Dec 2012 | Temporarily unavailable. Sandoz is targeting product availability for late December. | Shortage of an active ingredient. | Reverified 9/12/2012 |
300 mg, 100s (NDC 00185-4350-01) | Estimate available late-Dec 2012 | ||||
300 mg, 1000s (NDC 00185-4350-10) | Estimate available late-Dec 2012 | ||||
100 mg – 30s (NDC 00185-4351-30) | Product currently available. | ||||
100 mg, 100s (NDC 00185-4351-01) | |||||
100 mg, 1000s (NDC 00185-4351-10) | |||||
VersaPharm Service: 1-800-548-0700 | 300 mg, 30s (NDC 61748-0013-30) | Information pending | Other | ||
300 mg, 100s (NDC 61748-0013-01) | |||||
300 mg, 1000s (NDC 61748-0013-10) | |||||
100mg, 100s (NDC 61748-0016-01) |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
Bedford Customer Service | 15 mg/mL 1 mL vial, 10 count (NDC 55390-0480-01) | Bedford has all presentations of ketorolac injection on back order and the company cannot estimate a release date | Shortage per Manufacturer: Manufacturing delays | Discontinuation of the manufacture of the drug. | |
| 30 mg/mL 1 mL vial, 10 count (NDC 55390-0481-01) | |||||
| 30 mg/mL 10 mL vial, 10 count (NDC 55390-0481-10) | |||||
| American Regent/Luitpold 1-800-645-1706 | 15 mg/mL 1 mL vial, 25 count (NDC 00517-0601-25) | Unavailable | American Regent/Luitpold is not manufacturing Ketorolac Tromethamine Injection, USP | Discontinuation of the manufacture of the drug. | Reverified 8/31/2012 |
| 30 mg/mL 1 mL vial, 25 count (NDC 00517-0801-25) | |||||
| 30 mg/mL 2 mL vial for intramuscular use, 25 count (NDC 00517-0902-25) | |||||
| Wockhardt Customer Service: 1-800-346-6854 | 30 mg/mL 1 mL vial, 10 count (NDC 64679-0758-04) | Wockhardt is presently experiencing intermittent releases throughout the month | Demand increase for the drug. | Revised 8/17/2012 | |
| 30 mg/mL 1 mL vial, 25 count (NDC 64679-0758-01) | |||||
| 30 mg/mL 2 mL vial, 10 count (NDC 64679-0758-06) | |||||
| 30 mg/mL 2 mL vial, 25 count (NDC 64679-0758-02) | |||||
| 15 mg/mL 1 mL vial, 10 count (NDC 64679-0757-02) | Presently on backorder. An estimated release date is in the latter part of July. | ||||
| 15 mg/mL 1 mL vial, 25 count (NDC 64679-0757-01) | |||||
APP | 15 mg/mL 1 mL vial, 25 count (NDC 63323-0161-01) | APP has all presentations of ketorolac injection on back order and the company cannot estimate a release date. | Shortage per Manufacturer: | Shortage of an active ingredient. | Reverified 8/27/2012 |
| 30 mg/mL 1 mL vial, 25 count (NDC 63323-0162-01) | |||||
| 30 mg/mL 2 mL vial for intramuscular injection, 25 count (NDC 63323-0162-02) | |||||
Hospira, Inc. | 15 mg/mL; 1 mL vial (NDC 0409-3793-01) | Next delivery August/Estimated recovery 1Q 2013 | 15 mg/mL; 1 mL Carpuject (NDC 0409-2288-31) and 30 mg/mL; 2 mL Carpuject Shortage per Manufacturer: | Demand increase for the drug. | Revised 8/31/2012 |
| 15 mg/mL; 1 mL Carpuject (NDC 0409-2288-31) | Suspended production | ||||
| 30 mg/mL; 1mL vial (NDC 0409-3795-01) | Next delivery August/Estimated recovery 1Q 2013 | ||||
| 30 mg/mL; 1 mL Carpuject (NDC 0409-2287-31) | Next delivery August/Estimated recovery August | ||||
| 30 mg/mL; 2 mL Carpuject (NDC 0409-2287-61) | Suspended production | ||||
| 60 mg/mL; 2 ml vial (NDC 0409-3796-01) | Next delivery August/Estimated recovery 1Q 2013 |
